Clinical trials: Recruiting
Blood Donors
The Effect of Recruiting Inactive Blood Donors Using Different Means
14098 inactive donors were randomly divided into three groups according to age, sex, blood donation frequency,time of last donation and blood donation site, one group acted as the control group, one will be recruited by telephone…
- Trial name
- NCT04078893
- Testing
- telephone recruitment
- Where
- China
- Volunteers
- 14,098 people, healthy volunteers welcome
- Sponsor
- Guangzhou Blood Center
Blood Donor
The Effective Ways of Recruiting Lapsed Blood Donors: a Stratified Randomized Pilot Study
Blood donor recruitment is an important issue in every country, since the blood supply pressure become more and more intense. Donor retention is even more important, because it is easier to recruit an old customers than a new…
- Trial name
- NCT02646059
- Testing
- Text message, Telephone
- Where
- China
- Volunteers
- 1,188 people
- Sponsor
- Guangzhou Blood Center
Parental Consent, Newborn
Recruiting to Clinical Trials on the Telephone
This study examined the use of the telephone for the purpose of informing expectant mothers about a randomized clinical trial assessing neonatal Bacille Calmette-Guérin vaccination.
- Conditions
- Parental Consent, Newborn, Vaccination
- Trial name
- NCT02570061
- Testing
- telephone, consultation face-to-face
- Volunteers
- 125 people, healthy volunteers welcome
- Sponsor
- Gorm Greisen
Anesthesia, General, Surgery
Physiological Effects of Lung Recruitment During General Anesthesia and Low-tidal Volume Ventilation
Low-tidal volume ventilation is arising as a tool to optimize the ventilatory management and to improve clinical outcome in patients undergoing general anesthesia for abdominal surgery.
- Trial name
- PEEP-RM (NCT03083457)
- Testing
- Fluid resuscitation or amine administration, General anesthetic, Fluid administration
- Where
- Italy
- Volunteers
- 30 people
- Sponsor
- Catholic University of the Sacred Heart
Colorectal Cancer, Triple Negative Breast Cancer
A Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Patients With Solid Tumors or Lymphoma (Toca 6)
The purpose of this trial is to evaluate changes in immune activity relative to baseline following treatment with Toca 511 and Toca FC in patients with solid tumors (including recurrent high grade glioma [rHGG]) or lymphoma.
- Conditions
- Colorectal Cancer, Triple Negative Breast Cancer, Pancreatic Cancer, Non-Small Cell Lung Cancer
- Trial name
- NCT02576665
- Testing
- Toca 511, Toca FC
- Where
- 3 sites in United States
- Volunteers
- 21 people
- Sponsor
- Tocagen Inc.
Survey
Using Survey to Explore Perceptions of Adults With Low Socioeconomic Status Regarding the NutriQuébec Study
Populations with low socioeconomic status (SES) are more likely to develop diseases across lifespan and are frequently underrepresented in large cohort studies.
- Trial name
- NCT03847584
- Testing
- Survey
- Where
- Canada
- Volunteers
- 418 people, healthy volunteers welcome
- Sponsor
- Laval University
Lung Ultrasound
Ultrasonographic Assessment of the Effect of CPB Acute Lung Injury
The study is designed to use the lung ultrasound to assess the effect of intermittent lung recruitment during cardiopulmonary bypass in cardiac surgeries on extra vascular lung water.
- Trial name
- CBP (NCT03619525)
- Testing
- lung recruitment
- Where
- Egypt
- Volunteers
- 60 people, healthy volunteers welcome
- Sponsor
- Cairo University
Smoking Cessation
Use of Nicotine Replacement Therapy (NRT) Sample and Brief Smoking Cessation Advice for Recruiting Smokers
Background More than 60% of the daily smokers in Hong Kong have never tried and have no intention to quit smoking. About 30.8% of daily smokers attempted to quit but failed.
- Trial name
- NCT03717051
- Testing
- Nicotine replacement therapy (NRT) sampling, Medication counseling
- Where
- Hong Kong
- Volunteers
- 834 people, healthy volunteers welcome
- Sponsor
- The University of Hong Kong
Acute Myelogenous Leukemia, Acute Myeloid Leukemia
MCLA-117 in Acute Myelogenous Leukemia
This is a First-in-Human, single arm, open-label, multi-national study designed to determine the safety, tolerability and preliminary efficacy of MCLA 117.
- Trial name
- NCT03038230
- Testing
- MCLA-117 bispecific antibody
- Where
- 9 sites in United States, Belgium and 3 more
- Volunteers
- 80 people
- Sponsor
- Merus B.V.
Healthy Volunteers
Recruiting Blood Donor With Allogeneic Natural Killer Cell
This study on manufacture of MG4101 (allogeneic natural killer cell) to use for Hepatocellular carcinoma(HCC) after Transarterial Chemoembolization(TACE) will be harvested WBC(white blood cell) and plasma from healthy donors, or…
- Trial name
- NCT02716571
- Testing
- Leukapheresis or Plasmapheresis
- Where
- South Korea
- Volunteers
- 90 people, healthy volunteers welcome
- Sponsor
- Seoul National University Hospital
Malaria
Safety, Tolerability, Pharmacokinetics and Protective Efficacy of MAM01 in Healthy Adults
This is a First-in-Human (FiH), randomized, two-part, dose-escalation trial of MAM01 monoclonal antibody (mAb) targeting the Plasmodium falciparum (Pf) Circumsporozoite Protein (CSP).
- Trial name
- NCT05891236
- Testing
- MAM01 1.5 mg/kg, MAM01 5 mg/kg, MAM01 10 mg/kg
- Where
- United States
- Volunteers
- 63 people, healthy volunteers welcome
- Sponsor
- Gates Medical Research Institute
Lung Transplant
International EXPAND Lung Pivotal Trial
To evaluate the safety and effectiveness of the OCS™ Lung to recruit, preserve and assess donor lungs that may not meet current standard donor lung acceptance criteria for transplantation.
- Trial name
- EXPANDLung (NCT01963780)
- Testing
- OCS Lung Preservation
- Where
- 11 sites in United States, Belgium and 2 more
- Volunteers
- 79 people
- Sponsor
- TransMedics
Alcohol Use Disorder, Alcohol Dependency
Project Relay Model for Recruiting Alcohol Dependent Patients in General Hospitals
The purpose of this study is to evaluate the Relay Model helping alcohol dependent patients at a general hospital to start specialized alcohol treatment in order to assess i) efficacy, ii) cost-effectiveness and iii) overall…
- Trial name
- Relay (NCT02188043)
- Testing
- Relay Model
- Where
- Denmark
- Volunteers
- 1,000 people
- Sponsor
- University of Southern Denmark
Disaster Medicine, Delivery of Health Care
ESCAPE (Evaluating Surge Capacity And PrEparedness)
The ESCAPE study intends to assess the possibility of recruiting students as surge capacity work force in hospitals in the event of a major medical incident such as an epidemic or pandemic.
- Trial name
- ESCAPE (NCT06144008)
- Testing
- Answering questionnaire
- Where
- Germany
- Volunteers
- 3,000 people, healthy volunteers welcome
- Sponsor
- Ludwig-Maximilians - University of Munich
Healthy
Recruiting Healthcare Workers on the International Labor Market: A Megastudy
Public health organizations in Denmark and most Organization for Economic Cooperation and Development (OECD) countries face an urgent demand for nursing staff.
- Trial name
- MORE (NCT06793592)
- Testing
- Behaviorally informed recruitment message, Simplified direct message with no employer value proposition, No message
- Where
- Denmark
- Volunteers
- 110,000 people, healthy volunteers welcome
- Sponsor
- University of Aarhus
Postoperative Pain
Effect of Intraperitoneal Nebulisation of Magnesium Sulphate for Analgesia Following Laparoscopic Cholecystectomy
intraperitoneal nebulisation with magnesuim sulphate will reduce post operative pain and analgesic consumption in postoperative period following laparoscopic cholecystectomy.
- Trial name
- NCT01542697
- Testing
- intraperitoneal nebulisation of magnesium sulphate
- Where
- Nepal
- Volunteers
- 60 people
- Sponsor
- B.P. Koirala Institute of Health Sciences
Recruiting
A Study Comparing the Efficacy and Safety Between H-CHOP and R-CHOP in Untreated CD20-Positive Diffuse Large B-cell Lymphoma Patients
This trial is a Multicenter, randomized, double-blind, parallel, controlled, and equivalence phase Ⅲ study. Primary objective: The purpose is to compare the objective response rate of H02 (rituximab biosimilar) plus CHOP and…
- Trial name
- NCT05040906
- Testing
- H02+CHOP, Rituxan +CHOP
- Where
- China
- Volunteers
- 416 people
- Sponsor
- Shandong New Time Pharmaceutical Co., LTD